Using a variety of experimental approaches and cell lines, we show that STAG1 and STAG2 are synthetic lethal partners and provide evidence that STAG1 is a potential therapeutic target in tumours where STAG2 is inactive. This evidence concerns the gene STAG2 and neoplasm.